Levodopa with carbidopa and entacapone - Parkinson's disease
You are here : Home > Formulary Search > Levodopa with carbidopa and entacapone - Parkinson's disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Status 2
See narrative
Formulations :
- Intestinal gel
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an applicationto the APC.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Levodopa with carbidopa and entacapone
Indication :
Parkinson's disease
Group Name :
Keywords :
Brand Names Include :
Stalevo, Stanek, Sastravi, Lecigon
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Levodopa with carbidopa and entacapone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease.
- Amantadine hydrochloride
- Apomorphine hydrochloride
- Bromocriptine
- Cabergoline
- Clonazepam
- Co-beneldopa
- Co-careldopa
- Entacapone
- Foslevodopa with foscarbidopa
- Melatonin
- Opicapone
- Orphenadrine hydrochloride
- Pergolide mesilate
- Pramipexole
- Procyclidine hydrochloride
- Rasagiline mesilate
- Ropinirole hydrochloride
- Rotigotine
- Safinamide
- Selegiline hydrochloride
- Tolcapone
- Trihexyphenidyl hydrochloride
Committee Recommendations (1)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.